News Results

There are 724,290 News Results

May 22, 2018
EnerCom Adds Presenting Companies to its 23rd Annual - The Oil & Gas Conference® Roster
EnerCom Adds Presenting Companies to its 23rd Annual - The Oil & Gas Conference® Roster
Jun 5, 2018
North American Shale Producers, International Operators Join Roster of Presenting Companies for EnerCom's The Oil & Gas Conference®
DENVER, June 5, 2018 /PRNewswire/ -- EnerCom, Inc. is pleased to update the list of presenting oil and gas companies for the 23(rd) annual edition of The Oil & Gas...
Jul 24, 2018
Janssen Presents Switch Data for New HIV-1 Treatment SYMTUZA(TM) (D/C/F/TAF) and Second Study Supporting its Use in a Rapid Initiation Scenario
AMSTERDAM, July 24, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data reinforcing the safety and efficacy of switching to SYMTUZA(TM) (D/C/F/TAF) for the...
Aug 1, 2018
Parkinson's Disease Market 2018 by Phase of Development, Type of Treatment, Type of Molecule, Mechanism of Action, Route of Administration, and Leading Players
DUBLIN, Aug. 1, 2018 /PRNewswire/ -- The "Parkinson's Disease Market: Pipeline Review, Developer Landscape and Competitive Insights" report has been added to
Jun 2, 2017
Further Study of Combination of Eisai's Lenvatinib and Merck's Pembrolizumab in Previously Treated Patients with Metastatic Endometrial Cancer Supported by Interim Analysis of Ongoing Phase 1b/2 Trial
WOODCLIFF LAKE, N.J., June 3, 2017 /PRNewswire/ -- Eisai Inc. today announced interim results from the first evaluable cohort of Study 111, a Phase 1b/2 study investigating lenvatinib (marketed as...
Jun 6, 2017
Equity Strategies Snag All Top 20 Spots on eVestment Global Screening List; UK Users Globally Focused
ATLANTA, June 7, 2017 /PRNewswire/ -- All 20 of the most popular investment products viewed in May by institutional investment professionals using eVestment were equity focused in May 2017, according...
Jul 9, 2017
Global Next Generation Sequencers - Clinical Diagnostics
NEW YORK, July 10, 2017 /PRNewswire/ --
Jul 9, 2017
Global Acute Myeloid Leukemia (AML) Therapeutics - Pharmaceuticals
NEW YORK, July 10, 2017 /PRNewswire/ --
Jul 24, 2017
Eisai Submits Supplemental New Drug Application to FDA for Lenvatinib in First-Line Hepatocellular Carcinoma
WOODCLIFF LAKE, N.J., July 25, 2017 /PRNewswire/ -- Eisai Inc. today announced it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for the...
Sep 9, 2017
Combination of Lenvatinib and Pembrolizumab Results in Notable Response Rates for Patients with Advanced Renal Cell Carcinoma Based on Interim Analysis of Ongoing Phase 1b/2 Trial
WOODCLIFF LAKE, N.J., Sept. 10, 2017 /PRNewswire/ -- Eisai Inc. today announced interim results from the advanced renal cell carcinoma (RCC) cohort of Study 111, a Phase 1b/2 study investigating...
72429

Pages

1

Stories of the day

Oct 9, 2025
Viasat Awarded Contract by U.S. Space Force for Protected Tactical SATCOM-...
Oct 9, 2025
Damen Naval signs contract with Terma A/S for Decoy Launching System on...
Oct 10, 2025
INVISIO signs framework agreement worth up to SEK 365 million with Netherlands...
Oct 10, 2025
Rheinmetall to supply Leopard 1-based Skyranger 35 to Ukraine – contract value...